Target intelligence / Profile preview

MYO9A antisense RNA 1 (MYO9A-AS1)

Target
MYO9A-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

MYO9A antisense RNA 1 (MYO9A-AS1) is a predicted long non-coding RNA transcript located antisense to the MYO9A gene. Its specific sequence, biological function, and relevance as a therapeutic target are uncharacterized. In general, antisense RNAs may regulate their sense gene partners at the transcriptional or post-transcriptional level, but no direct data exists for MYO9A-AS1. There is no evidence of disease association, drug targeting, or biomarker relevance for MYO9A-AS1, and it should not be considered a validated drug target. This entry is likely to be a gene prediction or annotation artifact, rather than a functionally established molecular entity. Caution should be exercised when considering MYO9A-AS1 as a drug target, biomarker, or having any clinical significance.

Other names
MYO9A-AS1
02

Mechanism of action

No specific mechanisms available for MYO9A-AS1; for antisense RNAs in general: Can modulate mRNA stability, translation, or epigenetic marks. Antisense oligonucleotides can induce RNase H-mediated RNA degradation (general for antisense therapy, not for MYO9A-AS1 specifically).

03

Biological functions

Regulation of gene expression in cis or transChromatin organization (possible for antisense RNA in general)Possible involvement in transcriptional interferencePotential role in epigenetic regulation (by analogy to other antisense lncRNAs)
04

Disease associations

No direct evidence for MYO9A-AS1; in general, some antisense lncRNAs may be associated with cancer or imprinting disorders; for MYO9A-AS1, no specific disease associations are found.
05

Safety considerations

None specific to MYO9A-AS1; for antisense therapeutics in general, concerns may include off-target effects, toxicity, and immune activation

Beyond the preview

Go deeper on MYO9A antisense RNA 1 (MYO9A-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYO9A antisense RNA 1 (MYO9A-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call